Rosanna Mancari

ORCID: 0000-0002-9726-3653 · 6 papers in corpus
other 2025
Scientific reports ·doi:10.1038/s41598-025-00906-6

In Europe, endometrial carcinoma was found to be the fourth most common tumor in the female population in 2022. The depth of myometrial invasion is a well-established and crucial prognostic risk factor in endometrial cancer patients and is …

review 2020
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.13248

Surgery in suspected/confirmed COVID-19 patients is a high-risk venture. In infected patients, COVID-19 is present in the body cavity. During surgery it could be nebulized in the spray generated by surgical instruments and could theoretical…

observational 2018
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.19026

OBJECTIVE: To describe the clinical and ultrasound characteristics of ovarian pure endometrioid carcinomas. METHODS: This was a retrospective multicenter study of patients with a histological diagnosis of pure endometrioid carcinoma. We id…

observational 2018
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.19171

OBJECTIVE: To describe the clinical and ultrasound characteristics of ovarian pure clear cell carcinoma. METHODS: This was a retrospective study involving data from 11 ultrasound centers. From the International Ovarian Tumor Analysis (IOTA…

observational 2017
·doi:10.1002/uog.17885

To describe clinical and ultrasound features of ovarian clear cell carcinoma (CCC). Patients with a histological diagnosis of ovarian CCC, who had undergone preoperative ultrasound examination, were retrospectively identified from ten ultra…

case-report 2008
·doi:10.1002/uog.5807

Primary ovarian fibrosarcoma is one of the rarest ovarian tumors. It is an aggressive malignant condition and there are no clinical guidelines for the management of patients. In the published reports, these ovarian malignancies present a gr…